United States · FDA National Drug Code directory

Symtuza

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
59676-800_a8468da1-a6e7-4a14-a108-23915ccaeee8
Product NDC
59676-800
Form
TABLET, FILM COATED
Composition / generic term
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide
Labeler
Janssen Products LP
Marketing category
NDA
Marketing start / end (source format)
20180717
Source listing expiry
20271231

Source-listed ingredients

  • DARUNAVIR — 800 mg/1
  • COBICISTAT — 150 mg/1
  • EMTRICITABINE — 200 mg/1
  • TENOFOVIR ALAFENAMIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (59676-800-30) · 59676-800-30
  • 30 TABLET, FILM COATED in 1 BOTTLE (59676-800-99) · 59676-800-99

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Symtuza — United States | Molindra Medicines